144 related articles for article (PubMed ID: 18838918)
1. Podoplanin (D2-40) is a highly effective marker of follicular dendritic cells.
Marsee DK; Pinkus GS; Hornick JL
Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):102-7. PubMed ID: 18838918
[TBL] [Abstract][Full Text] [Related]
2. Follicular dendritic cells in reactive and neoplastic lymphoid tissues: a reevaluation of staining patterns of CD21, CD23, and CD35 antibodies in paraffin sections after wet heat-induced epitope retrieval.
Bagdi E; Krenacs L; Krenacs T; Miller K; Isaacson PG
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):117-24. PubMed ID: 11396628
[TBL] [Abstract][Full Text] [Related]
3. Use of Smooth Muscle Myosin Heavy Chain as an Effective Marker of Follicular Dendritic Cells.
Ioannidis I; Laurini JA
Appl Immunohistochem Mol Morphol; 2019 Jan; 27(1):48-53. PubMed ID: 28549038
[TBL] [Abstract][Full Text] [Related]
4. Podoplanin (d2-40): a new immunohistochemical marker for reactive follicular dendritic cells and follicular dendritic cell sarcomas.
Xie Q; Chen L; Fu K; Harter J; Young KH; Sunkara J; Novak D; Villanueva-Siles E; Ratech H
Int J Clin Exp Pathol; 2008 Jan; 1(3):276-84. PubMed ID: 18784810
[TBL] [Abstract][Full Text] [Related]
5. Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors.
Yu H; Gibson JA; Pinkus GS; Hornick JL
Am J Clin Pathol; 2007 Nov; 128(5):776-82. PubMed ID: 17951199
[TBL] [Abstract][Full Text] [Related]
6. Folliculocentric B-cell-rich follicular dendritic cells sarcoma: a hitherto unreported morphological variant mimicking lymphoproliferative disorders.
Lorenzi L; Lonardi S; Petrilli G; Tanda F; Bella M; Laurino L; Rossi G; Facchetti F
Hum Pathol; 2012 Feb; 43(2):209-15. PubMed ID: 21835430
[TBL] [Abstract][Full Text] [Related]
7. Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphoma.
Troxell ML; Schwartz EJ; van de Rijn M; Ross DT; Warnke RA; Higgins JP; Natkunam Y
Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):297-303. PubMed ID: 16280657
[TBL] [Abstract][Full Text] [Related]
8. SSTR2a Is a Useful Diagnostic Marker for Follicular Dendritic Cells and Their Related Tumors.
Tao LL; Huang YH; Chen YL; Yu GY; Yin WH
Am J Surg Pathol; 2019 Mar; 43(3):374-381. PubMed ID: 30585825
[TBL] [Abstract][Full Text] [Related]
9. Follicular dendritic cell tumor of the cervical lymph node.
Hangai K; Nonaka S; Iwakiri H; Kobayashi Y; Hayashi T; Harabuchi Y; Miyokawa N
ORL J Otorhinolaryngol Relat Spec; 2002; 64(3):229-32. PubMed ID: 12037393
[TBL] [Abstract][Full Text] [Related]
10. Follicular dendritic cell sarcoma: clinicopathologic study of 15 cases with emphasis on novel expression of MDM2, somatostatin receptor 2A, and PD-L1.
Agaimy A; Michal M; Hadravsky L; Michal M
Ann Diagn Pathol; 2016 Aug; 23():21-8. PubMed ID: 27402219
[TBL] [Abstract][Full Text] [Related]
11. Complement receptors CD21 and CD35 in humoral immunity.
Roozendaal R; Carroll MC
Immunol Rev; 2007 Oct; 219():157-66. PubMed ID: 17850488
[TBL] [Abstract][Full Text] [Related]
12. Follicular dendritic cells in follicular lymphoma and types of non-Hodgkin lymphoma show reduced expression of CD23, CD35 and CD54 but no association with clinical outcome.
Jin MK; Hoster E; Dreyling M; Unterhalt M; Hiddemann W; Klapper W
Histopathology; 2011 Mar; 58(4):586-92. PubMed ID: 21401698
[TBL] [Abstract][Full Text] [Related]
13. Frequent expression of follicular dendritic cell markers in Hodgkin lymphoma and anaplastic large cell lymphoma.
Kim SH; Choe JY; Jeon Y; Huh J; Jung HR; Choi YD; Kim HJ; Cha HJ; Park WS; Kim JE
J Clin Pathol; 2013 Jul; 66(7):589-96. PubMed ID: 23454725
[TBL] [Abstract][Full Text] [Related]
14. Dysplastic follicular dendritic cells in hyaline-vascular Castleman disease: a rare occurrence creating diagnostic difficulty.
Medina EA; Fuehrer NE; Miller FR; Kinney MC; Higgins RA
Pathol Int; 2016 Sep; 66(9):535-9. PubMed ID: 27593552
[TBL] [Abstract][Full Text] [Related]
15. γ-Synuclein is a promising new marker for staining reactive follicular dendritic cells, follicular dendritic cell sarcoma, Kaposi sarcoma, and benign and malignant vascular tumors.
Zhang H; Maitta RW; Bhattacharyya PK; Florea AD; Sen F; Wang Q; Ratech H
Am J Surg Pathol; 2011 Dec; 35(12):1857-65. PubMed ID: 21959308
[TBL] [Abstract][Full Text] [Related]
16. [Follicular dendritic cell sarcoma: a clinicopathologic analysis of ten cases].
Yin WH; Yu GY; Ma Y; Rao HL; Lin SX; Shao CK; Liang Q; Guo N; Chen GQ; Zhou W; Zhao T; Zhu MG
Zhonghua Bing Li Xue Za Zhi; 2010 Aug; 39(8):522-7. PubMed ID: 21055030
[TBL] [Abstract][Full Text] [Related]
17. Identification of CXCL13 as a new marker for follicular dendritic cell sarcoma.
Vermi W; Lonardi S; Bosisio D; Uguccioni M; Danelon G; Pileri S; Fletcher C; Sozzani S; Zorzi F; Arrigoni G; Doglioni C; Ponzoni M; Facchetti F
J Pathol; 2008 Nov; 216(3):356-64. PubMed ID: 18792075
[TBL] [Abstract][Full Text] [Related]
18. Expression of EGFR and follicular dendritic markers in lymphoid follicles from patients with Castleman's disease.
Lee J; Ban JY; Won KY; Kim GY; Lim SJ; Lee S; Kim YW; Park YK; Lee SS
Oncol Rep; 2008 Oct; 20(4):851-6. PubMed ID: 18813826
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical patterns of follicular dendritic cell meshwork and Ki-67 in small B-cell lymphomas].
Shi YF; Li XH
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):222-6. PubMed ID: 23928527
[TBL] [Abstract][Full Text] [Related]
20. Large B-cell lymphoma with T-cell-rich background and nodules lacking follicular dendritic cell meshworks: description of an insufficiently recognized variant.
Treetipsatit J; Metcalf RA; Warnke RA; Natkunam Y
Hum Pathol; 2015 Jan; 46(1):74-83. PubMed ID: 25456392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
